glp-1 stock market How to Invest in Drugs: Stocks and Funds to Watch GLP-1 Receptor Agonist Market Valued

At 48 weeks, the 8 mg group showed 22.8% mean body weight reduction, exceeding maximum tirzepatide dosing results

With GLP-1 penetration still at roughly 2% of the obese population globally, even a modest increase in uptake represents enormous commercial expansion

This effect can be particularly beneficial for patients who seek to manage their weight effectively and sustainably

Late 2020s: TRIUMPH-CVOT readout, enabling broader cardiovascular-risk-reduction labeling

So they're essentially just playing a numbers game

While you cannot obtain GLP-1 directly from food, your dietary choices profoundly influence how much GLP-1 your own intestinal cells produce and release